143 related articles for article (PubMed ID: 3025308)
1. Antiviral activities of human monoclonal antibodies to herpes simplex virus.
Fujinaga S; Sugano T; Matsumoto Y; Masuho Y; Mori R
J Infect Dis; 1987 Jan; 155(1):45-53. PubMed ID: 3025308
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
3. Ability of monoclonal antibody to herpes simplex virus glycoprotein gB to promote healing of herpetic skin lesions in nude mice.
Yamamoto M; Tang JL; Kumano Y; Mori R; Kino Y
Antiviral Res; 1986 Jul; 6(4):223-31. PubMed ID: 3017202
[TBL] [Abstract][Full Text] [Related]
4. Protection against zosteriform spread of herpes simplex virus by monoclonal antibodies.
Mester JC; Glorioso JC; Rouse BT
J Infect Dis; 1991 Feb; 163(2):263-9. PubMed ID: 1846388
[TBL] [Abstract][Full Text] [Related]
5. Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus.
Kino Y; Eto T; Ohtomo N; Hayashi Y; Yamamoto M; Mori R
Microbiol Immunol; 1985; 29(2):143-9. PubMed ID: 2989659
[TBL] [Abstract][Full Text] [Related]
6. Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2.
Bystrická M; Vancíková M; Kasalová M; Rajcáni J; Kostál M; Murányiová M; Poláková K; Russ G
Acta Virol; 1991 Apr; 35(2):152-64. PubMed ID: 1681713
[TBL] [Abstract][Full Text] [Related]
7. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
8. IgG subtype is correlated with efficiency of passive protection and effector function of anti-herpes simplex virus glycoprotein D monoclonal antibodies.
Ishizaka ST; Piacente P; Silva J; Mishkin EM
J Infect Dis; 1995 Oct; 172(4):1108-11. PubMed ID: 7561190
[TBL] [Abstract][Full Text] [Related]
9. Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus.
Forrester AJ; Sullivan V; Simmons A; Blacklaws BA; Smith GL; Nash AA; Minson AC
J Gen Virol; 1991 Feb; 72 ( Pt 2)():369-75. PubMed ID: 1704412
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of purified glycoprotein gB of herpes simplex virus.
Kino Y; Eto T; Nishiyama K; Ohtomo N; Mori R
Arch Virol; 1986; 89(1-4):69-80. PubMed ID: 3013134
[TBL] [Abstract][Full Text] [Related]
11. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
Chan WL; Lukig ML; Liew FY
J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential.
De Logu A; Williamson RA; Rozenshteyn R; Ramiro-Ibañez F; Simpson CD; Burton DR; Sanna PP
J Clin Microbiol; 1998 Nov; 36(11):3198-204. PubMed ID: 9774565
[TBL] [Abstract][Full Text] [Related]
13. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
[TBL] [Abstract][Full Text] [Related]
14. Hybridomas producing human monoclonal antibodies against varicella-zoster virus.
Sugano T; Matsumoto Y; Miyamoto C; Masuho Y
Eur J Immunol; 1987 Mar; 17(3):359-64. PubMed ID: 3032647
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
[TBL] [Abstract][Full Text] [Related]
16. Passive immunotherapy for encephalitis caused by herpes simplex virus.
Erlich KS; Mills J
Rev Infect Dis; 1986; 8 Suppl 4():S439-45. PubMed ID: 3018895
[TBL] [Abstract][Full Text] [Related]
17. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
Sanchez-Pescador L; Paz P; Navarro D; Pereira L; Kohl S
J Infect Dis; 1992 Sep; 166(3):623-7. PubMed ID: 1380051
[TBL] [Abstract][Full Text] [Related]
18. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
Roberts PL; Duncan BE; Raybould TJ; Watson DH
J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and characteristics of monoclonal antibodies to protein E2 (GP55) of classical hog cholera virus].
Kostina LV; Nepoklonov EA; Zaberezhnyĭ AD; Valikhov AF; Kozlov AIu
Vopr Virusol; 2008; 53(5):36-40. PubMed ID: 19069792
[TBL] [Abstract][Full Text] [Related]
20. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2.
McDermott MR; Brais LJ; Evelegh MJ
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1497-504. PubMed ID: 2165134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
